March 20, 2012 2:33 PM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
According to a research report published earlier today, Wedbush has increased NuPathe Inc.'s (NASDAQ: PATH) PT from $17 to $18.In the report, Wedbush commented, “We see PATH potentially doubling or more in 2012 and reiterate our Outperform rating and are increasing our fair value to $18 for time value. With potential approval by year-end 2012 and PATH having a lead asset which could reach peak sales of $300 million or more, we believe the stock is an attractive buying opportunity. We calculate PATH's fair value based on a 30% annual discount and a 1x-10x premium range on our net peak annual sales estimate for each product and indication in the clinic to reflect risk.”NuPathe is currently trading at $4.13.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.